CTOs on the Move

NanoHybrids

www.nanohybrids.net

 
NanoHybrids specializes in research and commercialization of nanotechnology-based products that enhance diagnosis and therapy for cancer and other diseases through enhanced molecular imaging and profiling. Our molecular imaging nanoparticles enhance contrast in vitro and in vivo across multiple biomedical imaging modalities. We are the leading provider of silica-coated gold nanoparticles optimized for photoacoustic (optoacoustic) imaging. With conjugation services we provide nanoparticles with high specificity for targeted cell receptors and tailored to individual applications. Our nanoparticles improve signal strength and allow real time imaging of functional biology. Interested in learning how we are using nanotechnology to drive advances in the life-sciences? ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Justin Harris
Chief Technology Officer Profile

Similar Companies

1-800 Wheelchair.com

1-800 Wheelchair.com is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Amulet Pharmaceutical

Amulet Pharmaceutical is a Halethorpe, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shamrock Marketing De

Shamrock Marketing De, Inc. is a Chino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IMRIS

As the intraoperative imaging expert, IMRIS, Deerfield Imaging measurably improves patient outcomes through planning, product integration and clinical workflow to give surgeons access to diagnostic quality scans in operating room suites. The IMRIS Surgical Theatre, which uniquely transport MR and CT scanners to the patient using ceiling-mounted rails and incorporate other IMRIS imaging technology, are sold globally to hospitals that deliver clinical services to patients in neurosurgical, spinal, interventional and orthopedic markets.

Optident

Optident is a Springfield, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.